Partnership to identify target Peptides
Start-up SanegeneBio Inc, focused on developing novel RNAi-based medicines has entered into a Master Service Agreement with Orbit Discovery (Oxford UK), a leader in the discovery of therapeutic peptide hits. Click to read more...